Dermapharm Holding SE (LON:0A5J)
38.10
-0.70 (-1.80%)
At close: Mar 27, 2025
Dermapharm Holding SE Revenue
In the year 2024, Dermapharm Holding SE had annual revenue of 1.20B EUR with 3.89% growth. Dermapharm Holding SE had revenue of 295.67M in the quarter ending December 31, 2024, with 7.85% growth.
Revenue
1.20B EUR
Revenue Growth
+3.89%
P/S Ratio
1.76
Revenue / Employee
331.15K EUR
Employees
3,610
Market Cap
1.74B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.20B | 44.72M | 3.89% |
Dec 31, 2023 | 1.15B | 110.19M | 10.59% |
Dec 31, 2022 | 1.04B | 80.46M | 8.38% |
Dec 31, 2021 | 960.09M | 151.78M | 18.78% |
Dec 31, 2020 | 808.31M | 93.94M | 13.15% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
Shell | 227.10B |
HSBC Holdings | 48.93B |
Unilever | 50.25B |
Rio Tinto Group | 42.86B |
RELX PLC | 9.43B |
British American Tobacco p.l.c. | 25.87B |
Rolls-Royce Holdings | 18.91B |